OG DNA Genetics, a globally recognized leading cannabis brand, today announced a licensing agreement with UNIVO Pharmaceuticals LTD (“UNIVO”), an Israel-based medical cannabis company trading on the Tel Aviv stock exchange under the symbol UNVO.TA. This Agreement will grant UNIVO license to the DNA brand and access to their proprietary library of award-winning genetics (including Kosher Kush) for use at the company’s 5-acre cultivation facility located in the south of Israel. Rezwan Khan, President of DNA Genetics said “Through this partnership, we will be able to bring our unique varieties to Israel and develop new and exciting cannabis-derived medicinal products to export internationally. We couldn’t ask for a better partner to enter the Israeli medical cannabis market with than UNIVO Pharmaceuticals.”
mg Magazine – Cannabis News & Information, 06/01/2021 06:52:00